SCHEMBL6946973

SCHEMBL6946973

COc1cc(Cc2ccccc2)cc(C(=O)CC(=O)C(=O)O)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
ERCC5 P28715 4/20 0.44
FEN1 P39748 4/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42
TUBB8 Q3ZCM7 1/20 0.42
TUBA3E Q6PEY2 1/20 0.42
TUBA1A Q71U36 1/20 0.42
TUBA1C Q9BQE3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946187 0.90 PTPN1 (0.47) KDM4ENPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6949353 0.89 TUBB4A (0.40) KDM4EERCC5FEN1NPC1RAB9A
SCHEMBL6948187 0.89 ERCC5 (0.40) KDM4EERCC5FEN1NPC1SMN1; SMN2
SCHEMBL6945647 0.89 SMN1; SMN2 (0.47) KDM4EERCC5FEN1NPC1RAB9A
SCHEMBL6951318 0.88 ERCC5 (0.39) KDM4EERCC5FEN1NPC1SMN1; SMN2
SCHEMBL6951319 0.88 ERCC5 (0.39) KDM4EERCC5FEN1NPC1SMN1; SMN2
SCHEMBL6943470 0.88 ERCC5 (0.50) KDM4EERCC5FEN1NPC1LMNA
Dimethylamine SCHEMBL6943493 0.87 LMNA (0.42) KDM4EERCC5FEN1RAB9ASMN1; SMN2
SCHEMBL6940790 0.87 KDM4E (0.41) KDM4ENPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6943825 0.86 ERCC5 (0.43) KDM4EERCC5FEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082121-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-02-05 EP claimed
US-6380249-B1 HIV integrase inhibitors MERCK & CO., INC. 2002-04-30 US claimed
EP-1082121-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-14 EP claimed
WO-1999062520-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1082121-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-02-05 EP disclosed
US-6380249-B1 HIV integrase inhibitors MERCK & CO., INC. 2002-04-30 US disclosed
EP-1082121-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-14 EP disclosed
WO-1999062520-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed